DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
eBay
EBAY
Collegium Pharmaceutical
COLL
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Lantheus
LNTH
US Stock MarketDetailed Quotes
ALGS Aligos Therapeutics
- 8.897
- -0.763-7.90%
Trading Mar 28 14:54 ET
54.40MMarket Cap-0.42P/E (TTM)
9.759High8.880Low45.73KVolume9.530Open9.660Pre Close422.13KTurnover1.05%Turnover RatioLossP/E (Static)6.11MShares46.80052wk High-1.88P/B38.91MFloat Cap6.76052wk Low--Dividend TTM4.37MShs Float937.748Historical High--Div YieldTTM9.09%Amplitude6.760Historical Low9.231Avg Price1Lot Size
About Aligos Therapeutics Company
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). The company was founded by Lucinda Quan and Lawrence M. Blatt on February 5, 2018 and is headquartered in South San Francisco, CA.
Company Profile
SymbolALGS
Company NameAligos Therapeutics
Listing DateOct 16, 2020
Issue Price15.00
Founded2018
CEODr. Lawrence M. Blatt,PhD
MarketNASDAQ
Employees70
Fiscal Year Ends12-31
Address1 Corporate Drive,2nd floor
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-800-466-6059
Websitehttp://www.aligos.com
Company Executives
- Name
- Position
- Salary
- Dr. Lawrence M. Blatt,PhD
- President, Chairman of the Board and Chief Executive Officer
- 1.34M
- Julian A. Symons, D.Phil.
- Executive Vice President and Chief Scientific Officer
- 836.32K
- Lesley Ann Calhoun
- Chief Operating Officer, Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Margarita Chavez, J.D.
- Director
- --
- Dr. Heather Elizabeth Preston, M.D.
- Director
- --
- Carole L. Nuechterlein, J.D.
- Independent Director
- 12.90K
- James Scopa
- Independent Director
- 67.90K
- Dr. K. Peter Hirth, PhD
- Independent Director
- 60.40K
- Dr. Bridget A. Martell, M.D.
- Independent Director
- 52.90K